Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2024-05-10 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-05-10 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Curocom) regarding the adjustment of the conversion price of convertible bonds. This type of filing, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category as it directly impacts the company's capital structure and potential future share dilution.
2024-04-30 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, formal notification regarding a change in the company's market classification (from Venture Enterprise to Mid-sized Enterprise) on the stock exchange. It does not contain financial statements, management discussions, or other substantive reports. As it is a brief regulatory notification that does not fit into specific categories like M&A or dividends, it is classified as a general regulatory filing.
2024-04-30 Korean
유형자산취득결정(종속회사의주요경영사항)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Curocom) regarding the acquisition of tangible assets (real estate) by its subsidiary. It follows the standard format for 'Major Management Matters' (주요경영사항) filings required by the Korea Exchange (KRX). Since it details a specific corporate transaction (asset acquisition) that does not fit into the more specific categories like M&A, share issuance, or dividend announcements, it is classified as a general Regulatory Filing.
2024-04-24 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding the 'Acquisition of Shares and Securities of Other Corporations' (타법인주식및출자증권취득결정). It is a formal amendment (정정신고) to a previous disclosure. Since this document details a specific corporate transaction (investment/acquisition) and does not fit into the specific categories like M&A (which usually implies a merger or takeover of a significant entity) or other specialized categories, it is best classified as a general regulatory filing.
2024-04-23 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a '합병등종료보고서' (Report on Completion of Merger, etc.) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a material asset acquisition (real estate) by the company (주)크레오에스지. Since this document reports the finalization of a specific corporate transaction (asset acquisition/merger-related activity) rather than a general regulatory announcement or a report publication notice, it falls under the category of M&A Activity (TAR) as it pertains to the completion of a significant corporate restructuring or asset transfer event.
2024-04-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.